Biography

Richard Martin is Professor of Clinical Epidemiology, Honorary Consultant in Public Health and NIHR Senior Investigator. He is Lead PI of CRUK’s Integrative Cancer Epidemiology Programme (2015-2025; £11.9 Million), which has provided robust evidence on metabolic pathways in cancer leading to funded prevention trials, discovered a lung CT screening biomarker for smoking-based risk stratification being validated in an NHS trial, and implemented lifestyle (e.g., diet and physical activity) interventions for prostate cancer in the NHS. He leads the world's largest randomised trial of prostate cancer screening (CAP trial; n=413,000; published JAMA 2018) that updated UK (2020) and USA (2018) screening policy, reducing harms and saving an estimated £1billion/year in NHS costs. He is Co-I on a linked prostate cancer treatment trial (ProtecT, n=82,429 PSA tested; published NEJM 2016), incorporated into NICE recommendations (2018) for evidence-based UK practice. He co-leads the long-term follow-up of the world’s largest randomised controlled trial of breastfeeding promotion (n=17,000), that has led to >30 papers on effects of breastfeeding on obesity (JAMA 2017), eczema (JAMA Pediatr 2018), IQ (PLOS Medicine 2018) and childhood eating attitudes (IJE 2014), and which supports NICE breastfeeding recommendations. As of May 2021, he has been awarded £33.1Million as PI and £77.4Million as co-I since 1999 and has 356 peer-reviewed publications, 54 cited >100 and 3 >1000 times. He is lead/senior-author on 141 of these 356 publications (Scopus h index: 68).